-

Cutera® Announces Partnership with the Adaptive Training Foundation

Cutera collaborates with Dr. Edward Alvarez to provide truFlex® muscle stimulation treatments to help enhance the strength and endurance of adaptive athletes

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announces their partnership with the Adaptive Training Foundation (ATF), a non-profit organization that provides access and inclusion to individuals living with physical or traumatic impairments empowering them through exercise and community.

The Cutera team, with the support of Edward Alvarez, DDS, C.Ac, owner of Madison Avenue Face and Body, has provided ATF participants with truFlex muscle stimulation treatments to enhance strength, muscle tone, and endurance as ATF members undergo a vigorous nine-week training course. This specialized course, ReDefine, crafted by ATF, offers customized training with a group of individuals who are experiencing similar struggles. The athletes receive physical training and the tools to redefine their sense of self through mindfulness and mental training.

"I first learned about ATF through the incredible story of Makala Noble, a former high school athlete who was paralyzed in a tumbling accident, who displayed an unwavering dedication to recovery," said Dr. Alvarez. "Makala’s determination, combined with the powerful work ATF is doing on such a broad scale, instantly inspired me. Many of my patients have benefited from enhanced core strength with truFlex, so offering it to those who need specialized treatment options to help improve their quality of life felt like a natural fit."

A survey study was also performed to evaluate the improvement in quality of life and the physical benefits of incorporating truFlex into the ReDefine training program.3 Many participants praised their treatment experience and noted improvements in areas they have struggled to progress, such as their abdomen, glutes, and thighs.

“Cutera’s truFlex technology has unlocked innovative new pathways for our ATF athletes to increase muscle function and create newfound body-empowerment,” said David Vobora, ATF Founder. “We are excited to see the potential this device has on a population that is underserved and can be greatly impacted by its technology.”

truFlex is the first muscle stimulation device to deliver energy to specific muscle groups in a convenient, 15-minute treatment. It covers the largest body surface area of any device in the industry and can replicate up to 54,000 contractions to increase muscle mass up to 30% in areas including the abdomen, obliques, thighs, and glutes after one treatment series.1,2

Cutera plans to donate the truFlex device at the end of the year to continue treatments for future cohorts of adaptive athletes and aid in the positive work of the Adaptive Training Foundation.

“We are honored to partner with such a worthwhile organization to share the positive effects of our unique muscle stimulation technology,” said Taylor Harris, CEO of Cutera. “This is just the start of our efforts to explore the additional benefits of truFlex while continuing to grow the body of evidence that supports the use of truFlex across multiple therapeutic indications.”

Interested providers and patients can visit yourtrubody.com to learn more about truFlex, and hear stories from patients about their experiences. For more information on the Adaptive Training Foundation, interested parties can visit www.adaptivetrainingfoundation.org.

About Cutera, Inc.

Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. For over 25 years, Cutera has strived to improve lives through medical aesthetic technologies that are driven by science and powered through partnerships. For more information, call 1-888-4-CUTERA or visit Cutera.com.

About Adaptive Training Foundation

The Adaptive Training Foundation provides access and inclusion to individuals living with physical or traumatic impairments by empowering them through exercise and community.

Important safety and risk information about truFlex is available by contacting Cutera at cutera.com/us-en/global-offices/. Patients should talk to their healthcare provider.

1 Ronan SJ. A Novel Bio-Electric Current Stimulation Device for Improvement of Muscle Tone [white paper, Cutera Inc.]. 7/2019.
2 Nye R, Hoffmeister A. The Process of Muscle Hypertrophy Utilizing a Novel Bio-electrical Muscle Stimulation Device [white paper, Cutera Inc.]. 1/2020.
3 Data on file.

Contacts

Cutera Media:
EvolveMKD
Cutera@EvolveMKD.com

Adaptive Training Foundation Media:
Katherine O’Hara
kohara@oharaproject.com

CUTERA, INC.

NASDAQ:CUTR
Details
Headquarters: Brisbane, CA
CEO: Taylor Harris
Employees: 450
Organization: PUB
Revenues: $252 million (2022)
Net Income: NM (2022)

Release Versions

Contacts

Cutera Media:
EvolveMKD
Cutera@EvolveMKD.com

Adaptive Training Foundation Media:
Katherine O’Hara
kohara@oharaproject.com

More News From CUTERA, INC.

Cutera Announces Voluntarily Delisting from Nasdaq

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (“Cutera” or the “Company”) (Nasdaq: CUTR) today announced that it has formally notified The Nasdaq Stock Market LLC (“Nasdaq”) of its intent to voluntarily delist its common stock from the Nasdaq Global Select Market. Cutera expects to file a Form 25 with the Securities and Exchange Commission (the "SEC") relating to the voluntary delisting of its common stock on or about March 20, 2025. The Company expects the delisting of the common stock to be...

Cutera Takes Steps to Strengthen Financial Foundation and Position the Company for Long-Term Success

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC., (“Cutera” or “the Company”), a leading provider of aesthetic and dermatology solutions, today announced that it is initiating a restructuring transaction with the support of a group of existing lenders, representing approximately 74% of the Company’s notes, to strengthen its balance sheet and position Cutera for long-term success. Through the transaction, Cutera will reduce its debt by nearly $400 million, or over 90%, and raise $65 million in ne...

Cutera® Announces Third Quarter 2024 Financial Results

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today reported financial results for the third quarter ended September 30, 2024. Consolidated revenue for the third quarter of 2024 of $32.5 million Cash, cash equivalents, and restricted cash of $59.0 million AviClear growth of 16% vs prior year period driven by international capital system sales Global core capital growth of 7% on a sequential quarterly basis Full-year gu...
Back to Newsroom